Pain Management, Opioid Use and the Registration of Distributors of Controlled Substances in Rhode Island (216-RICR-20-20-4)


216-RICR-20-20-4 PROPOSED RULE

Title 216 Department of Health
Chapter 20 Community Health
Subchapter 20 Drugs
Part 4 Pain Management, Opioid Use and the Registration of Distributors of Controlled Substances in Rhode Island (216-RICR-20-20-4)
Type of Filing Amendment
Regulation Status Proposed View Active Rule
Filing Notice Date 04/12/2019
Filing Hearing Date(s) 04/24/2019
Public Comment Dates 04/12/2019 to 05/13/2019

Regulation Authority :

R.I. Gen. Laws § 21-28-3.01

Purpose and Reason :

In accordance with R.I. Gen. Laws § 42­35­2.7, notice is hereby given that the  Rhode Island Department of Health (RIDOH) proposes to amend the rules and   regulations for Pain Management, Opioid Use and the Registration of Distributors of  Controlled Substances in Rhode Island (216-­RICR-­20-20-4­). RIDOH is proposing rulemaking to create requirements for e­prescriptions, implement grammatical  corrections and revise the use of several terms including MME and PDMP, eliminate  definitions that are not utilized in the regulations or that are being replaced with  updated terms, create definitions for electronic prescription, standing order, and  substance use disorder, clarify mandatory PDMP review, clarify requirements for  documentation of patient education regarding opioids, clarify requirements for ICD10 code equivalents as determined by RIDOH, revise/remove section titles, and  correct references to other RIDOH regulations. Please see the attached Concise  Statement of Non­technical Amendments for a full description of all proposed  revisions.

0

Comments Received*

*This count refers to the total comment submissions received on this document, as of 11:59 PM yesterday.
Note: Agencies review all submissions; however, some agencies may choose to withhold certain submissions such as those containing private or sensitive information, profane or threatening language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and the actual number of comments displayed on this page. For specific information about a comment you submitted, please contact the agency directly.